Market Access & HTA Japan
Join industry executives in staying informed on the market access and HTA process in Japan.
Healthcare system and funding, healthcare actors and payers, post-market approval processes and regulations, price control and reference pricing systems, HTA decision analysis frameworks, HTA dossier requirements, data requirements, managed entry agreements, public procurement and tendering, expenditure control and cost containment policies, essential drug lists, orphan drugs, and vaccines.
The Pharma Legal Handbook: Market Access & HTA Guide is a must-have asset for any company operating in Japan or looking to enter the market.
Prepared in association with Nishimura & Asah, one of the leading corporate law firms in Japan.
If The Pharma Legal Handbook: Market Access & HTA Guide content is updated, you will receive an updated PDF free for up to one year after purchase.